Volker Straub Selected Research

2,2,2',4'-tetrachloroacetophenone

1/2020	The Latin American experience with a next generation sequencing genetic panel for recessive limb-girdle muscular weakness and Pompe disease.
4/2015	Conserved expression of truncated telethonin in a patient with limb-girdle muscular dystrophy 2G.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Volker Straub Research Topics

Disease

47	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2022 - 07/2002
34	Muscular Dystrophies (Muscular Dystrophy) 01/2022 - 03/2002
30	Muscular Diseases (Myopathy) 11/2022 - 10/2002
20	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 01/2021 - 11/2004
12	Muscle Weakness 10/2021 - 08/2007
11	Disease Progression 01/2021 - 01/2013
10	Glycogen Storage Disease Type II (Pompe's Disease) 05/2022 - 07/2013
9	Cardiomyopathies (Cardiomyopathy) 12/2019 - 05/2009
8	Rare Diseases (Rare Disease) 02/2016 - 01/2013
5	Sarcoglycanopathies 01/2022 - 12/2008
5	Fibrosis (Cirrhosis) 01/2021 - 05/2009
5	Limb-girdle muscular dystrophy type 2A 01/2020 - 12/2007
5	Bethlem myopathy 01/2020 - 12/2013
4	Dysferlinopathy 01/2022 - 12/2005
4	Type 2I Limb-Girdle Muscular Dystrophy 01/2020 - 01/2005
4	Neuromuscular Diseases (Neuromuscular Disease) 01/2020 - 11/2013
4	Scleroatonic muscular dystrophy 01/2020 - 01/2013
4	Distal Myopathies (Distal Muscular Dystrophy) 11/2017 - 07/2008
4	type 2B Limb-girdle muscular dystrophy 09/2015 - 06/2007
4	Miyoshi myopathy 09/2010 - 03/2007
3	Muscle Hypotonia (Hypotonia) 10/2021 - 02/2012
3	Inborn Genetic Diseases (Disease, Hereditary) 01/2020 - 01/2008
3	Walker-Warburg Syndrome 01/2020 - 03/2002
3	Scoliosis 01/2017 - 02/2012
3	Limb-girdle muscular dystrophy type 2F 01/2013 - 12/2008
3	Ophthalmoplegia (External Ophthalmoplegia) 09/2011 - 08/2007
2	Muscular Atrophy (Muscle Atrophy) 11/2022 - 01/2011
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2022 - 07/2021
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022 - 10/2021
2	Osteoporosis 01/2022 - 01/2021
2	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 10/2021 - 11/2020
2	Camptocormia 01/2021 - 06/2013
2	Left Ventricular Dysfunction 01/2021 - 05/2009
2	Intellectual Disability (Idiocy) 11/2020 - 03/2017
2	Respiratory Insufficiency (Respiratory Failure) 01/2020 - 03/2014
2	Cataract (Cataracts) 05/2017 - 03/2017
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 07/2014 - 09/2009
2	Myasthenia Gravis 04/2014 - 03/2011
2	Myofibrillar Myopathy 03/2014 - 05/2009
2	Hereditary Myopathy with Early Respiratory Failure 03/2014 - 06/2012
2	Ehlers-Danlos Syndrome (Syndrome, Ehlers-Danlos) 09/2013 - 02/2012
2	Malignant Hyperthermia 06/2013 - 08/2007
2	1 Rippling muscle disease 03/2011 - 07/2008
2	Heart Failure 11/2010 - 06/2009
2	Central Core Myopathy (Central Core Disease) 08/2007 - 06/2002
2	Minicore Myopathy with External Ophthalmoplegia 10/2002 - 06/2002
1	Metabolic Bone Diseases (Osteopenia) 01/2022

Drug/Important Bio-Agent (IBA)

29	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2004
20	DystrophinIBA 10/2021 - 05/2009
12	Creatine Kinase (Creatine Phosphokinase)IBA 11/2022 - 01/2005
12	Biomarkers (Surrogate Marker)IBA 11/2020 - 01/2013
9	CollagenIBA 01/2021 - 11/2009
9	DysferlinIBA 11/2019 - 12/2005
8	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 11/2009
8	Sarcoglycans (beta Sarcoglycan)IBA 01/2022 - 12/2008
8	Dystroglycans (Dystroglycan)IBA 01/2018 - 03/2002
6	GlucosidasesIBA 05/2022 - 07/2013
6	GlucocorticoidsIBA 01/2022 - 01/2016
6	Pharmaceutical PreparationsIBA 01/2022 - 08/2011
6	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 06/2013 - 06/2002
5	GlycogenIBA 05/2022 - 01/2016
5	AcidsIBA 05/2022 - 07/2016
5	AntibodiesIBA 11/2021 - 12/2007
5	ConnectinIBA 01/2020 - 06/2012
5	CalciumIBA 01/2020 - 08/2007
4	human GAA protein (Myozyme)FDA Link 12/2021 - 01/2015
4	Antisense OligonucleotidesIBA 01/2021 - 01/2014
4	SteroidsIBA 01/2021 - 05/2009
4	CalpainIBA 01/2020 - 12/2007
3	golodirsenIBA 01/2022 - 01/2020
3	MorpholinosIBA 01/2021 - 10/2009
3	MicroRNAs (MicroRNA)IBA 11/2020 - 01/2013
3	eteplirsenIBA 10/2012 - 10/2009
3	protein O-mannose beta-1,2-N-acetylglucosaminyltransferaseIBA 11/2008 - 03/2002
2	deflazacortIBA 01/2022 - 01/2020
2	EnzymesIBA 12/2021 - 01/2021
2	Testosterone (Sustanon)FDA Link 04/2021 - 12/2015
2	Troponin IIBA 01/2021 - 09/2015
2	EP3533IBA 01/2021 - 01/2019
2	Contrast MediaIBA 01/2021 - 12/2004
2	Biological ProductsIBA 01/2020 - 11/2014
2	Malate Dehydrogenase (Dehydrogenase, Malate)IBA 01/2020 - 07/2014
2	2,2,2',4'-tetrachloroacetophenoneIBA 01/2020 - 04/2015
2	MyostatinIBA 03/2017 - 05/2008
2	RNA (Ribonucleic Acid)IBA 01/2017 - 04/2016
2	Phosphotransferases (Kinase)IBA 01/2017 - 03/2014
2	Myosin Light Chains (Myosin Essential Light Chain)IBA 09/2015 - 07/2014
2	Fibronectins (Fibronectin)IBA 04/2014 - 03/2014
2	Calcium Channels (Calcium Channel)IBA 01/2013 - 01/2011
2	Metoprolol (Toprol-XL)FDA LinkGeneric 01/2013 - 11/2010
2	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 12/2011 - 07/2002
2	Caveolin 3IBA 03/2011 - 07/2008
2	Prednisolone (Predate)FDA LinkGeneric 01/2010 - 05/2009
2	CytokinesIBA 06/2009 - 05/2009
1	Growth Hormone (Somatotropin)IBA 01/2022
1	Insulin (Novolin)FDA Link 01/2022

Therapy/Procedure

25	Therapeutics 12/2021 - 11/2010
4	Enzyme Replacement Therapy 05/2022 - 07/2013
2	Noninvasive Ventilation 05/2017 - 12/2013
1	Continuous Positive Airway Pressure 11/2022